Answers are grounded in this paper and cite their sources.
The IDI-MRSA assay has a sensitivity of 96% and a specificity of 96% when used to screen patients at extranasal sites. This verification study used previously unverified swabs and was undertaken in a core medical laboratory using nonmicrobiology technologists trained in sample processing, molecular laboratory work flow, and PCR practice.
No takes yet. Share an insight, caveat, or question.
Drews et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: